miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1764-1770

  Cai, Cheng Kui ^a   Zhao, Guang Yi ^a   Tian, Li Ying ^a   Liu, Lie ^b   Yan, Kang ^a   Ma, Yun Lei ^a   Ji, Zhen Wei ^a   Li, Xiao Xiang ^a   Han, Kang ^a   Gao, Jie ^a   Qiu, Xiu Chun ^a   Fan, Qing Yu ^a   Yang, Tong Tao ^a   Ma, Bao An ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Baoji Center Hospital   (China)

Author keywords

Apoptosis; Cell cycle; Crucial modulators of cyclin D1; MiR 15a; MiR 16 1; Osteosarcoma

Indexed keywords

CYCLIN D1; MESSENGER RNA; MICRORNA 15A; MICRORNA 16; MICRORNA 16 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE ARREST; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYCLIN D1 GENE; DNA STRAND BREAKAGE; DOWN REGULATION; FLOW CYTOMETRY; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; ONCOGENE; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

3' UNTRANSLATED REGIONS; APOPTOSIS; BONE NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OSTEOSARCOMA; TRANSCRIPTION, GENETIC;

EID: 84866436241     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1995     Document Type: Article

References (34)

1. Kosacka M, Piesiak P, Porebska I, et al: The cyclin A, B1, D1, and E expression in advanced non-small cell lung cancer - stages IIIB-IV (preliminary report). Pol Merkur Lekarski 30: 253-258, 2011 (in Polish).
2. Chen RW, Bemis LT, Amato CM, et al: Truncation in CCND1 mRNA alters miR-16-1 regulation in mantel cell lymphoma. Blood 112: 822-829, 2008.
3. Miska EA: How microRNAs control cell division, diffentiation and death. Curr Opin Genet Dev 15: 563-568, 2005.
4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Carè A, Catalucci D, Felicetti F, et al: MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618, 2007. (Pubitemid 46828487)
6. Bandi N, Zbinden S, Gugger M, et al: miR-15a and miR-16-1 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553-5559, 2009.
7. Tsang WP and Kwok TT: Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21: 140-146, 2010.
8. Guo CJ, Pan Q, Jiang B, Chen GY and Li DG: Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 14: 1331-1340, 2009.
9. Xu F, Zhang X, Lei Y, et al: Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J Cell Biochem 111: 727-734, 2010.
10. Bhattacharya R, Nicoloso M, Arvizo R, et al: MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69: 9090-9095, 2009.
11. Bonci D, Coppola V, Musumeci M, et al: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277, 2008.
12. Xia L, Zhang DX, Du R, et al: miR-15b and miR-16-1 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008. (Pubitemid 351842022)
13. Bottoni A, Piccin D, Tagliati F, et al: miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280-285, 2005. (Pubitemid 40776831)
14. Nedelcu T, Kubista B, Koller A, et al: Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res Clin Oncol 134: 237-244, 2008. (Pubitemid 350234069)
15. Gao J, Yang TT, Qiu XC, et al: Cloning and identification of microRNA from human osteosarcoma cell line SOSP-9607. Ai Zheng 26: 561-565, 2007 (In Chinese).
16. Tsang TY, Tang WY, Chan JY, et al: P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellar carcinoma cells. Apoptosis 16: 524-535, 2011.
17. Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL-2. Proc Natl Acad Sci USA 102: 13944-13949, 2005. (Pubitemid 41377683)
18. Lerner M, Harada M, Lovén J, et al: DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 315: 2941-2952, 2009.
19. Shan LQ, Ma S, Qiu XC, et al: A novel recombinant immune-tBid with a furin site effectively suppresses the growth of HER2-positive osteosarcoma cells in vitro. Oncol Rep 25: 325-331, 2011.
20. Wang LF, Zhou Y, Xu YM, et al: A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma. Cancer Invest 27: 774-780, 2009.
21. Chen X, Yang TT, Wang W, et al: Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology 61: 37-44, 2009.
22. Sherr CJ: D-type cyclins. Trends Biochem Sci 20: 187-190, 1995.
23. Motokura T, Bloom T, Kim HG, et al: A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350: 512-515, 1991. (Pubitemid 21912266)
24. Liu Q, Fu H, Sun F, et al: miR-16-1 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391-5404, 2008.
25. Iaquinta PJ and Lees JA: Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19: 649-657, 2007. (Pubitemid 350216426)
26. Wu X and Levine AJ: p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91: 3602-3606, 1994. (Pubitemid 24139478)
27. Han EK, Ng SC, Arber N, Begemann M and Weinstein IB: Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis. Apoptosis 4: 213-219, 1999. (Pubitemid 29378789)
28. Moroni MC, Hickman ES, Lazzerini Denchi E, et al: Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3: 552-558, 2001. (Pubitemid 32536851)
29. Han J, Flemington C, Houghton AB, et al: Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 98: 11318-11323, 2001. (Pubitemid 32928726)
30. Nakano K and Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001. (Pubitemid 32706359)
31. Oda E, Ohki R, Murasawa H, et al: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000. (Pubitemid 30324238)
32. Fortin A, MacLaurin JG, Arbour N, et al: The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem 279: 28706-28714, 2004. (Pubitemid 38900155)
33. Hershko T and Ginsberg D: Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279: 8627-8634, 2004. (Pubitemid 38295917)
34. Polager S and Ginsberg D: P53 and E2f: partners in life and death. Nat Rev Cancer 9: 738-748, 2009.